Antineoplastic properties of pyrimidinone interferon inducers.
D000818:Animals; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D007109:Immunity / Q000187:drug effects; D007369:Interferon Inducers / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood; D008545:Melanoma / Q000188:drug therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D008813:Mice, Inbred ICR; D011743:Pyrimidines / Q000627:therapeutic use; D011744:Pyrimidinones / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy
D007369:Interferon Inducers; D011743:Pyrimidines; D011744:Pyrimidinones; C014927:2-amino-5-bromo-6-methyl-4-pyrimidinol; C033561:2-amino-5-iodo-6-phenyl-4-pyrimidinone; D003596:Cytosine; D007372:Interferons; C033560:bropirimine